ArticleNucleic acids research2026
The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
HELQ is a 3'-5' DNA helicase whose loss sensitizes cells to DNA-damaging agents, particularly DNA crosslinkers. HELQ interacts with the RAD51 paralog complex RAD51B-RAD51C-RAD51D-XRCC2 (BCDX2), a key mediator of replication fork reversal. Using DNA fiber assays, we show that HELQ and BCDX2 act epistatically to slow replication fork progression under replication stress. Because fork reversal transiently regresses nascent strands into a four-way junction and reduces net DNA synthesis, this fork slowing provides a functional readout of fork reversal. Directly supporting this model, electron microscopy reveals that reversed fork structures are reduced in HELQ-knockout cells. Consistent with a role in fork reversal, HELQ deletion suppresses nascent strand degradation when BRCA2- or FANCD2-dependent fork protection is lost. Mechanistically, biochemical reconstitution shows that HELQ is stimulated by RPA on fork substrates containing a leading strand gap, and these findings are consistent with the cell-based DNA fiber assays. Together, these results identify HELQ as a specialized regulator of replication fork remodeling that promotes fork reversal through the BCDX2 pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.